封面
市場調查報告書
商品編碼
1298584

腫瘤學分子診斷市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Oncology Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2022年全球腫瘤學分子診斷市場規模達到37億美元。展望未來,IMARC Group預計到2028年市場規模將達到84億美元,在2023-2028年期間表現出14.9%的成長率(CAGR)。

腫瘤學分子診斷通過分析癌細胞的生物分子來確定其存在。對血液、唾液和腫瘤組織樣本進行若干測試,以檢測和測量DNA、RNA和細胞蛋白質中的特定基因序列。腫瘤學分子診斷有助於進行快速分析,並提供詳細資訊,進一步用於癌症的個性化治療。這些診斷解決方案在臨床和照護端(POC)測試中找到了應用,用於癌症的早期檢測。它們還被用於血庫,以識別捐贈的血液樣本中的病原體和傳染病。

由於生活方式的改變、老年人口的成長和吸煙趨勢的增加,癌症發病率的上升是推動全球腫瘤學分子診斷市場成長的主要因素之一。除此之外,對快速和準確診斷的需求不斷增加,以及下一代測序(NGS)技術的進步,也促進了市場的成長。此外,患有病毒和細菌感染的人數增加,以及越來越多的人參與捐血活動,都對全球腫瘤學分子診斷的需求產生了積極影響。然而,由於冠狀病毒疾病(COVID-19)的突然爆發,一些醫療機構正在採取措施,通過減少醫療預約的數量來減輕這種大流行病對癌症患者的風險。此外,由於提供COVID-19檢測的診斷資源被重新利用,腫瘤學檢測也隨之減少,對癌症患者的定期篩查也出現了下降。

本報告中回答的關鍵問題:

  • 迄今為止,全球腫瘤學分子診斷市場的表現如何,在未來幾年將如何表現?
  • COVID-19對全球腫瘤學分子診斷市場的影響是什麼?
  • 主要的區域市場是什麼?
  • 基於癌症類型的市場細分是什麼?
  • 基於產品的市場細分是什麼?
  • 基於技術的市場細分是什麼?
  • 基於終端用戶的市場細分是什麼?
  • 行業價值鏈中的各個階段是什麼?
  • 該行業的關鍵驅動因素和挑戰是什麼?
  • 全球腫瘤分子診斷市場的結構是什麼,誰是主要的參與者?
  • 該行業的競爭程度如何?

目錄

第一章:前言

第二章:範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章:執行摘要

第四章:簡介

  • 概述
  • 主要行業趨勢

第五章:全球腫瘤學分子診斷市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章:按癌症類型分類的市場

  • 乳腺癌
    • 市場趨勢
    • 市場預測
  • 前列腺癌
    • 市場趨勢
    • 市場預測
  • 結直腸癌
    • 市場趨勢
    • 市場預測
  • 宮頸癌
    • 市場趨勢
    • 市場預測
  • 肝癌
    • 市場趨勢
    • 市場預測
  • 肺癌
    • 市場趨勢
    • 市場預測
  • 血癌
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第7章:按產品分類的市場

  • 儀器
    • 市場趨勢
    • 市場預測
  • 試劑
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第8章:按技術分類的市場

  • 聚合酶鍊式反應(PCR)
    • 市場趨勢
    • 市場預測
  • 原位雜交技術
    • 市場趨勢
    • 市場預測
  • 晶片和微陣列
    • 市場趨勢
    • 市場預測
  • 等溫核酸擴增技術(INAAT)
    • 市場趨勢
    • 市場預測
  • 質譜分析法
    • 市場趨勢
    • 市場預測
  • DNA和NGS測序
    • 市場趨勢
    • 市場預測
  • 轉錄介導的擴增(TMA)
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第九章:按終端用戶分類的市場

  • 醫院和診所
    • 市場趨勢
    • 市場預測
  • 參考實驗室
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第十章:按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十一章:SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十二章:價值鏈分析

第十三章:波特五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十四章:價格分析

第十五章:競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • Agilent Technologies, Inc.
    • Abbott Laboratories
    • Bayer AG
    • Becton, Dickinson and Company
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Hologic, Inc.
    • Qiagen NV
    • Siemens Healthcare
    • Sysmex Corporation
Product Code: SR112023A2396

The global oncology molecular diagnostics market size reached US$ 3.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.4 Billion by 2028, exhibiting a growth rate (CAGR) of 14.9% during 2023-2028.

Oncology molecular diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell proteins. Oncology molecular diagnostics help perform rapid analysis and provide detailed information that is further utilized in the personalized treatment of cancer. These diagnostics solutions find application in clinical and point-of-care (POC) testing for early detection of cancer. They are also used in blood banks to identify pathogens and infectious diseases present in the donated blood samples.

The rising prevalence of cancer on account of changing lifestyles, growing geriatric population, and the increasing trend of smoking represents one of the major factors impelling the global oncology molecular diagnostics market growth. Apart from this, the escalating demand for rapid and accurate diagnosis, along with advancements in next generation sequencing (NGS) techniques, is contributing to the growth of the market. Furthermore, a rise in the number of individuals suffering from viral and bacterial infections and the increasing participation in blood donation campaigns is positively influencing the demand for oncology molecular diagnostics worldwide. However, due to the sudden outbreak of the coronavirus disease (COVID-19), several healthcare institutions are undertaking steps to mitigate the risk of the pandemic on cancer patients by reducing the number of medical appointments. Moreover, regular screening for cancer patients has witnessed a decline due to the repurposing of diagnostics resources for providing COVID-19 testing and consequent reduction in oncology testing.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology molecular diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on cancer type, product, technology and end-user.

Breakup by Cancer Type:

Breast Cancer

Prostate Cancer

Colorectal Cancer

Cervical Cancer

Liver Cancer

Lung Cancer

Blood Cancer

Others

Breakup by Product:

Instruments

Reagents

Others

Breakup by Technology:

Polymerase Chain Reaction (PCR)

In Situ Hybridization

Chips and Microarrays

Isothermal Nucleic Acid Amplification Technology (INAAT)

Mass Spectrometry

DNA and NGS Sequencing

Transcription Mediated Amplification (TMA)

Others

Breakup by End-User:

Hospitals and Clinics

Reference Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Inc., Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic, Inc., Qiagen N.V., Siemens Healthcare and Sysmex Corporation.

Key Questions Answered in This Report:

  • How has the global oncology molecular diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global oncology molecular diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global oncology molecular diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1   Preface

2   Scope and Methodology 

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Oncology Molecular Diagnostics Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Cancer Type

  • 6.1  Breast Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Prostate Cancer
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Colorectal Cancer
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Cervical Cancer
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Liver Cancer
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6  Lung Cancer
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7  Blood Cancer
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8  Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7   Market Breakup by Product

  • 7.1  Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Reagents
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8   Market Breakup by Technology

  • 8.1  Polymerase Chain Reaction (PCR)
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  In Situ Hybridization
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Chips and Microarrays
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4  Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5  Mass Spectrometry
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6  DNA and NGS Sequencing
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7  Transcription Mediated Amplification (TMA)
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast
  • 8.8  Others
    • 8.8.1 Market Trends
    • 8.8.2 Market Forecast

9   Market Breakup by End-User

  • 9.1  Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Reference Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast 
  • 9.3  Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  Agilent Technologies, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio 
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2  Abbott Laboratories
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio 
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3  Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio 
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4  Becton, Dickinson and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio 
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5  Danaher Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio 
      • 15.3.5.3 SWOT Analysis
    • 15.3.6  F. Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio 
      • 15.3.6.3 SWOT Analysis
    • 15.3.7  Hologic, Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio 
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8  Qiagen N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio 
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9  Siemens Healthcare
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio 
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10  Sysmex Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio 
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Oncology Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Oncology Molecular Diagnostics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Oncology Molecular Diagnostics Market: Breakup by Cancer Type (in %), 2022
  • Figure 4: Global: Oncology Molecular Diagnostics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Oncology Molecular Diagnostics Market: Breakup by Technology (in %), 2022 
  • Figure 6: Global: Oncology Molecular Diagnostics Market: Breakup by End-User (in %), 2022
  • Figure 7: Global: Oncology Molecular Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 9: Global: Oncology Molecular Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Oncology Molecular Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Oncology Molecular Diagnostics (Liver Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Oncology Molecular Diagnostics (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Oncology Molecular Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Oncology Molecular Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Oncology Molecular Diagnostics (Blood Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Oncology Molecular Diagnostics (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Oncology Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Oncology Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Oncology Molecular Diagnostics (Reagents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Oncology Molecular Diagnostics (Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Oncology Molecular Diagnostics (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Oncology Molecular Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification-TMA) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification-TMA) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Oncology Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Oncology Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028 
  • Figure 47: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028 
  • Figure 51: Global: Oncology Molecular Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Global: Oncology Molecular Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: North America: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: North America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: United States: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: United States: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Canada: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Canada: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Asia Pacific: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Asia Pacific: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: China: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: China: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Japan: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Japan: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: India: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: India: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: South Korea: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: South Korea: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Australia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Australia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Indonesia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Indonesia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Europe: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Europe: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Germany: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Germany: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: France: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: France: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: United Kingdom: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: United Kingdom: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Italy: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Italy: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Spain: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Spain: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Russia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Russia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Latin America: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Latin America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Brazil: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Brazil: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Mexico: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Mexico: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 97: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 98: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 99: Middle East and Africa: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 100: Middle East and Africa: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 101: Global: Oncology Molecular Diagnostics Industry: SWOT Analysis
  • Figure 102: Global: Oncology Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 103: Global: Oncology Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oncology Molecular Diagnostics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Cancer Type (in Million US$), 2023-2028
  • Table 3: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2023-2028 
  • Table 5: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 6: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Oncology Molecular Diagnostics Market Structure
  • Table 8: Global: Oncology Molecular Diagnostics Market: Key Players